DOT Drug Testing Rules: Complete Guide for Regulated Employees

DOT drug testing applies to all safety-sensitive employees in the following industries, regulated by their respective agencies:

FMCSA (Federal Motor Carrier Safety Administration): CDL (Commercial Driver's License) holders — truck drivers, bus drivers, hazmat transporters. This is the largest group of DOT-tested workers.

FAA (Federal Aviation Administration): Pilots, flight attendants, flight engineers, aircraft dispatchers, air traffic controllers, aviation security, and ground security coordinators.

FRA (Federal Railroad Administration): Railroad engineers, conductors, brakemen, switchmen, and dispatchers.

FTA (Federal Transit Administration): Bus drivers, rail operators, maintenance workers, security personnel, and dispatchers for public transit systems.

PHMSA (Pipeline and Hazardous Materials Safety Administration): Pipeline operations and maintenance workers, including those who handle hazardous materials.

USCG (United States Coast Guard): Merchant mariners, crew members on commercial vessels, and individuals holding Coast Guard-issued credentials.

If you work in any of these industries in a safety-sensitive role, DOT drug testing is mandatory — your employer cannot opt out, and neither can you.

Pre-employment: Required before you can perform safety-sensitive duties for the first time. You must pass the test before your first day on the job (or before being transferred into a safety-sensitive role). There is no exception — even if you passed a drug test at a previous employer.

Random: DOT requires employers to randomly test a minimum percentage of safety-sensitive employees each year: 50% for drugs and 10% for alcohol. Selection must be truly random (computer-generated), and you must report to the collection site as soon as practical after being notified — typically within 2 hours. You cannot refuse or delay a random test.

Post-accident: Required after certain accidents as defined by each DOT agency. For FMCSA (trucking), testing is required if there is a fatality, if a driver receives a citation and someone is taken to the hospital, or if a driver receives a citation and a vehicle must be towed. Drug testing must be completed within 32 hours and alcohol testing within 8 hours of the accident.

Reasonable suspicion: Triggered when a trained supervisor observes specific, articulable signs of drug or alcohol use during work hours. The supervisor must document their observations in writing. Two supervisors must observe and concur for alcohol testing; one is sufficient for drug testing.

Return-to-duty: Required before you can return to safety-sensitive duties after a positive test, refusal, or other DOT violation. You must first complete a SAP evaluation and follow the SAP's treatment recommendations. The return-to-duty test must be directly observed (a same-gender collector watches you provide the sample).

Follow-up: After returning to duty, you will be subject to unannounced follow-up testing for a minimum of 12 months. The SAP determines the schedule, with a minimum of 6 tests in the first 12 months. Follow-up testing can continue for up to 60 months at the SAP's discretion.

If you receive a positive DOT drug test or refuse to test, you are immediately removed from safety-sensitive duties and referred to a Substance Abuse Professional (SAP). The SAP process is mandatory — you cannot return to DOT-regulated work without completing it.

Step 1 — Initial SAP evaluation: You meet face-to-face with a DOT-qualified SAP (a licensed counselor, psychologist, social worker, or physician with SAP training). The SAP conducts a clinical assessment and determines what education and/or treatment you need.

Step 2 — Complete treatment: You must follow the SAP's recommendations, which may include education programs, outpatient treatment, inpatient treatment, or a combination. The specific requirements depend on your clinical assessment — there is no one-size-fits-all program.

Step 3 — Follow-up SAP evaluation: After completing treatment, you return to the SAP for a follow-up evaluation. The SAP determines whether you have complied with their recommendations and are ready to return to safety-sensitive duties.

Step 4 — Return-to-duty test: If the SAP clears you, you must pass a directly observed return-to-duty drug test (and alcohol test, if applicable) before returning to work.

Step 5 — Follow-up testing: The SAP creates a follow-up testing plan — a minimum of 6 unannounced tests in the first 12 months, with possible extension up to 60 months.

Cost: The SAP process, treatment, and follow-up testing are generally paid by the employee, not the employer. Costs vary widely depending on the treatment required but typically range from $500 to $5,000 or more. Some employer assistance programs (EAPs) may cover part of the cost.

The FMCSA Drug & Alcohol Clearinghouse is a federal database that tracks all DOT drug and alcohol violations for CDL (Commercial Driver's License) holders. It went into effect on January 6, 2020.

What is reported to the Clearinghouse: Positive drug test results, positive alcohol test results (BAC of 0.04 or higher), refusals to test, return-to-duty test results, and follow-up test completion. SAP reports (initial evaluation, treatment compliance, follow-up evaluation) are also recorded.

Who can see your Clearinghouse record: Current and prospective employers (with your consent), FMCSA investigators, and you (you can check your own record for free). Employers are required to query the Clearinghouse before hiring a new CDL driver and at least once per year for existing drivers.

How long violations stay on your record: A violation remains in the Clearinghouse until you complete the entire return-to-duty process (SAP evaluation, treatment, return-to-duty test, follow-up testing). Even after completion, the record is retained for 5 years from the date of the violation. During the 5-year period, prospective employers will see the resolved violation when they query your record.

Registering: All CDL holders should register for a Clearinghouse account at https://clearinghouse.fmcsa.dot.gov/. This allows you to check your own record, respond to employer queries, and monitor for any inaccurate entries.

Yes, you can get your CDL back after a positive DOT drug test, but you must complete the SAP (Substance Abuse Professional) process. There is no permanent CDL revocation solely for a drug test failure — the federal regulations provide a pathway back to driving.

Here is what you need to do: (1) Complete the SAP initial evaluation face-to-face. (2) Follow and complete the SAP's treatment recommendations. (3) Pass the SAP follow-up evaluation. (4) Pass a directly observed return-to-duty drug test. (5) Find an employer willing to hire you (the Clearinghouse violation will be visible to prospective employers). (6) Complete a minimum of 6 unannounced follow-up drug tests in the first 12 months.

Important reality check: While the regulations allow you to return, many trucking companies will not hire a driver with a Clearinghouse violation, especially a recent one. Larger carriers and those with strict insurance requirements may be unwilling to take the risk. However, some carriers specialize in hiring second-chance drivers — smaller companies, owner-operator opportunities, and regional carriers may be more willing. The violation stays on your Clearinghouse record for 5 years, so it becomes easier to find employment as time passes and you maintain a clean record.

Timeline: The SAP process typically takes 2 to 6 months to complete, depending on the treatment program recommended. After that, you need to find an employer, pass the return-to-duty test, and begin follow-up testing.

This is one of the most important things to understand about DOT drug testing: marijuana is a Schedule I controlled substance under federal law, and DOT is a federal agency. State marijuana legalization — whether recreational or medical — has absolutely no effect on DOT drug testing requirements.

If you test positive for THC on a DOT drug test, it is a violation regardless of whether you used marijuana in a state where it is legal, whether you have a medical marijuana card, whether you used marijuana off-duty, or whether you were not impaired at the time of the test. The DOT has issued multiple official statements confirming this position.

This means that CDL drivers, airline employees, railroad workers, transit workers, pipeline workers, and maritime workers cannot use marijuana in any form — including CBD products that may contain trace THC. Even delta-8 THC products (derived from hemp, legal in many states) can cause a positive DOT test.

If you are a DOT-regulated employee and use marijuana, you are risking your career, your CDL, and a Clearinghouse violation that will follow you for 5 years.

In 2023, the DOT finalized a rule allowing oral fluid (saliva) testing as an alternative to urine testing for DOT drug tests. This is a significant change that affects all DOT-regulated industries.

Key points about DOT oral fluid testing: Employers can choose to use oral fluid testing instead of or in addition to urine testing. The test screens for the same 5 substances as the urine test (THC, cocaine, opioids, amphetamines, PCP) but with cutoff levels specific to oral fluid. Oral fluid collection is directly observed by default — the collector watches the donor place the collection device in their mouth. This makes substitution and adulteration virtually impossible.

Advantages for employers: Easier to administer (no restroom needed), harder to cheat (directly observed), detects very recent use (useful for reasonable suspicion and post-accident testing). Advantages for employees: Less invasive than urine collection, no privacy concerns about being in a restroom.

Potential impact: Oral fluid testing detects THC for a shorter window (about 24 to 72 hours) compared to urine (3 to 30 days). This means occasional marijuana users may be less likely to test positive on an oral fluid test than a urine test. However, daily or heavy users will still test positive, and the DOT marijuana prohibition remains in full effect regardless of the test type.